RT-104 (Rani Therapeutics)

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameRT-104 (Rani Therapeutics)
Drug Alias NameRT-104
ClassificationOther
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRani Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesRani Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A